Clinical Study of Apatinib and XELOX Combination Regimen to Treat Colorectal Cancer Patients
收藏NIAID Data Ecosystem2026-03-09 收录
官方服务：
资源简介：
This study makes an observation over the objective response rate of Apatinib and XELOX combination regimen in the first-line treatment of metastatic colorectal cancer. All the participants will receive the treatment of Apatinib and XELOX combination regimen.
创建时间：
2016-06-15
